SLC1A3 and multiple sclerosis: It has been shown that pathological astrocyte activation in the EAE model of multiple sclerosis reduces HK2 activity,34 so it is possible that the increase measured in our study represents anti-inflammatory activation of astrocytes, as supported by the increase in Tgfb and Trem2 measured in GLAST+ cells.